FDA warns of ultrasound device problems after 4 deaths reported
DUANEWS | October 11, 2026 The U.S. Food and Drug Administration (FDA) has issued a serious safety alert involving Philips Lumify diagnostic ultrasound systems after the manufacturer reported four deaths and eight serious injuries…
DUANEWS | October 11, 2026
The U.S. Food and Drug Administration (FDA) has issued a serious safety alert involving Philips Lumify diagnostic ultrasound systems after the manufacturer reported four deaths and eight serious injuries associated with problems affecting the devices.
The warning, published October 9, 2026, concerns technical failures that could prevent medical professionals from performing ultrasound scans when they are urgently needed.
According to the FDA, the problems may delay diagnosis or treatment, particularly in emergency situations outside hospitals.
What is the problem?
Philips Lumify is a portable ultrasound system that allows healthcare professionals to perform diagnostic imaging using a compatible smartphone or tablet connected to an ultrasound probe.
The technology is used in hospitals, ambulances and other medical environments where rapid imaging can help doctors make critical decisions.
However, Philips identified a software problem that may cause the Lumify application to unexpectedly stop recognizing a previously registered ultrasound probe.
When this happens, the system can require users to register the probe again before scanning can resume.
The registration process requires an internet connection through Wi-Fi or a cellular network.
In locations without reliable connectivity, the device may become temporarily unusable, potentially delaying emergency medical care.
Philips also reported problems involving unstable USB connections between the ultrasound probe and the smartphone or tablet, which can interrupt scanning.
Four deaths and eight serious injuries reported
According to the FDA, Philips had reported eight serious injuries and four deaths associated with the device issues as of September 29, 2026.
These reports raise significant concerns about the potential consequences of ultrasound equipment failures during medical emergencies.
However, the reported association does not automatically establish that the device problems directly caused all four deaths or eight injuries. The circumstances and causal relationships require careful evaluation.
The FDA warned that interruptions in ultrasound imaging could delay diagnosis or treatment and, depending on a patient’s condition, could potentially result in serious injury or death.
Emergency medical services may face greater risks
The FDA emphasized that Lumify systems used outside hospitals may face additional challenges.
Ambulances, aircraft and remote medical locations may not have consistent access to Wi-Fi or cellular service.
If a device unexpectedly requires registration in one of these environments, medical professionals may be unable to resume scanning immediately.
Such delays can be especially concerning when doctors or paramedics need ultrasound imaging to assess a critically ill or injured patient.
Which devices are affected?
The alert covers several versions of Philips Lumify software used on Android and Apple iOS devices.
Affected iOS versions include 2.X, 5.0, 5.1.2 and 5.1.3.
Affected Android versions include 1.X, 3.X, 4.X, 5.1 and 5.1.1.
The FDA has published identifying information for the affected systems on its official website.
What should hospitals and medical professionals do?
Philips sent a notification to affected customers on September 24, recommending additional precautions.
Healthcare providers are advised to use Lumify systems only where reliable Wi-Fi or cellular connectivity is available, unless an alternative ultrasound device can be accessed immediately.
Medical facilities should also maintain backup ultrasound equipment and ensure that all personnel using Lumify systems are aware of the potential failures.
Philips says it is developing a software update to address the unexpected registration problem.
The company is also investigating the USB connection issue and working to identify an appropriate solution.
Is this an FDA recall?
The October 9 announcement is classified as an FDA Early Alert, rather than a newly announced FDA-ordered product removal.
The agency is collecting additional information about the potentially high-risk device issue.
Philips has issued updated use instructions to affected customers, while the FDA continues reviewing the situation.
FDA continues monitoring the situation
The FDA says it will update its public safety notice as significant new information becomes available.
The warning highlights the importance of reliable medical technology, particularly when healthcare professionals depend on portable diagnostic equipment during emergencies.
For hospitals and emergency medical providers, the immediate priority is ensuring that alternative equipment is available if an ultrasound system unexpectedly stops functioning.
Official source: U.S. Food and Drug Administration, Early Alert: Diagnostic Ultrasound System Issue from Philips Ultrasound, published October 9, 2026.
Conversation 0